T Cell–Depleted Partial Matched Unrelated Donor Transplant for Advanced Myeloid Malignancy: KIR Ligand Mismatch and Outcome
Authors:
- Daniel WeisdorfDaniel Weisdorf
- Sarah CooleySCSarah Cooley
- Steven DevineSDSteven Devine
- Todd A. FehnigerTodd A. Fehniger
- John DiPersioJDJohn DiPersio
- Claudio AnasettiCAClaudio Anasetti
- Edmund K. WallerEWEdmund K. Waller
- David PorterDPDavid Porter
- Sherif FaragSFSherif Farag
- William DrobyskiWDWilliam Drobyski
- Todd DeforTDTodd Defor
- Michael HaagensonMHMichael Haagenson
Open Access
- 1 June 2012
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 18 (6) , 937-943
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (2PO1 CA111412)
This publication has 31 references indexed in Scilit:
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemiaBlood, 2010
- Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemiaBlood, 2009
- Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.Blood, 2007
- Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCTBlood, 2007
- The Effect of KIR Ligand Incompatibility on the Outcome of Unrelated Donor Transplantation: A Report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch RegistryTransplantation and Cellular Therapy, 2006
- Full Haplotype-Mismatched Hematopoietic Stem-Cell Transplantation: A Phase II Study in Patients With Acute Leukemia at High Risk of RelapseJournal of Clinical Oncology, 2005
- The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemiaBlood, 2004
- Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donorsBlood, 2003
- Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplantsBlood, 2002
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002